Scaffold Technology Market Size Worth $2.1 Billion By 2028 | CAGR: 8.4%: Grand View Research, Inc.

May 26, 2021

Scaffold technology marketsize is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research,

SAN FRANCISCO, May 26, 2021 The global scaffold technology market size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be primarily attributed to the growing popularity of bioprinting for mimicking the tissue microenvironment in printed 3D tissue models. The need to expand the horizon of multidisciplinary research areas has supplemented the adoption of scaffold technologies in 3D printed models.

Key suggestions from the report:

The hydrogels segment dominated the market in terms of revenue in 2020 owing to advantages such as high biocompatibility, thermal reversibility, and strong cellular activities, contributing to its increasing adoption rate
The nanofiber-based scaffolds segment is expected to witness lucrative growth owing to the growing advancements such as 3D molding for developing 3D nanofiber membranes
The stem cell therapy, regenerative medicine, and tissue engineering segment held the largest revenue share in 2020
This growth is attributed to the expanding adoption of scaffolds in the aesthetic procedure, wound healing, periodontology, and colorectal surgeries
The drug discovery segment is expected to witness the fastest CAGR over the forecast period
Scaffolds play a vital role in the elucidation of molecular reasons for the activity of drug candidate in toxicity screening procedures, which is expected to impact the growth of medical technology in this segment
The orthopedics, musculoskeletal, and spine segment held a substantial market share in 2020 due to an increase in the popularity of regenerative medicines
Regenerative medicines can offer various lower risk substitutes to allograft surgery, thereby supplementing the adoption of the technology in this segment
The biotechnology and pharmaceutical industries segment dominated the market in terms of revenue share in 2020 owing to their high engagement in new drug discovery and development
North America held the largest revenue share in 2020. Growth in this region is owing to the presence of key players and extensive R&D activities
Companies operating in the market are entering into partnership for developing 3D cell culture models
For instance, in March 2021, PELOBiotech GmbH entered in partnership with Rigenerand SRL for developing 3D Cell Culture models. The company distributed its VITVO handheld bioreactor which is integrated with a scaffold for establishing in vitro 3D cell culture model that is used in pre-clinical investigations and research applications

Read 190 page research report with ToC on “Scaffold Technology Market Size, Share & Trends Analysis Report By Type, By Application (Stem Cell, Regenerative Medicine, Drug Discovery), By Disease Type (Cancer, Dental, Neurology), By End-use, And Segment Forecasts, 2021 – 2028” at: https://www.grandviewresearch.com/industry-analysis/scaffold-technology-market

For instance, in October 2021, researchers integrated novel biomaterial scaffold-guided regeneration for multiple periodontal tissues. The incorporation of advanced imaging modalities along with 3D printing has facilitated non-invasive tracking of in vivo degradation of scaffolds. The advent of such technologies is expected to propel the adoption of scaffolds in tissue engineering and regeneration, thereby providing considerable momentum to market growth.

Additionally, the development of novel diagnostic and therapeutic strategies such as tissue engineering, regenerative medicine, have been largely favored in the wake of the pandemic outbreak of SARS-COV-2 infection. Expanding research activities in the field of tissue engineering have led to the advent of scaffold-based vaccine systems, which have the potential tocombatCOVID-19. Progress in this area is expected to cause a surge in the adoption of advanced medical technologies in COVID-19 vaccine development and research.

Furthermore, researchers are proactively using in vitro human lung tissue models developed using tissue-engineered for the understanding of mechanisms of the infection and host-pathogen interface. The application of tissue engineering is used for culturing multiple pulmonary cell lines, improving the relevance of in vitro models, and the use of 3D scaffolds that mimic native pulmonary architecture.

Grand View Research has segmented the global scaffold technology market on the basis of type, application, disease type, end-use and region:

Scaffold Technology Type Outlook (Revenue, USD Million, 2017 – 2028)
- Hydrogels
  - Polymeric
  - Micropatterned Surface Microplates
  - Nanofiber-based
- Wound Healing
- 3D Bioprinting
- Immunomodulation
Scaffold Technology Application Outlook (Revenue, USD Million, 2017 – 2028)
- Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
- Drug Discovery
- Others
Scaffold Technology Disease Type Outlook (Revenue, USD Million, 2017 – 2028)
- Orthopedics, Musculoskeletal, & Spine
- Cancer
- Skin & Integumentary
- Dental
- Cardiology & Vascular
- Neurology
- Urology
- GI, Gynecology
- Others
Scaffold Technology End-use Outlook (Revenue, USD Million, 2017 – 2028)
- Biotechnology and Pharmaceutical Industries
- Research Laboratories and Institutes
- Hospitals and Diagnostic Centers
- Others
Scaffold Technology Regional Outlook (Revenue, USD Million, 2017 – 2028)
- North America
  - U.S.
  - Canada
- Europe
  - Germany
  - U.K.
- Asia Pacific
  - China
  - Japan
- Latin America
  - Brazil
- Middle East & Africa
  - South Africa

List of Key Players of Scaffold Technology Market

Merck KGaA
Thermo Fisher Scientific, Inc.
Becton, Dickinson, and Company
3D Biotek LLC
Xanofi
Molecular Matrix, Inc.
Tecan Trading AG
REPROCELL Inc.
Matricel GmbH
Pelobiotech
Corning Incorporated
Akron Biotech
Avacta Life Sciences Limited.
Nanofiber Solutions
4titude
Bioquote Ltd
Vericel Corporation
NuVasive, Inc.
Allergan
Medtronic

Find more research reports on Biotechnology Industry, by Grand View Research:

3D Cell Culture Market – The global 3D cell culture market size was valued at USD 1.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 10.7% during the forecast period.
Cell Culture Market – The global cell culture market size was estimated at USD 16.4 billion in 2014. Development of novel three-dimensional cell culture techniques and growing need for these techniques are expected to drive demand
Human Embryonic Stem Cells Market – The global Human Embryonic Stem Cells market size was valued at USD 494.7 million in 2015. These are the pluripotent cells that possess the ability to get differentiated into all germ layers.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter